Cheryl Bushnell to Estrogen Replacement Therapy
This is a "connection" page, showing publications Cheryl Bushnell has written about Estrogen Replacement Therapy.
Connection Strength
1.522
-
Lisabeth L, Bushnell C. Stroke risk in women: the role of menopause and hormone therapy. Lancet Neurol. 2012 Jan; 11(1):82-91.
Score: 0.364
-
Bushnell C. Stroke Hormones and Outcomes in Women (SHOW) study: is the 'healthy-user effect' valid for women after stroke? Womens Health (Lond). 2009 Sep; 5(5):485-96.
Score: 0.310
-
Bushnell CD. Hormone replacement therapy and stroke: the current state of knowledge and directions for future research. Semin Neurol. 2006 Feb; 26(1):123-30.
Score: 0.242
-
Bushnell CD. Oestrogen and stroke in women: assessment of risk. Lancet Neurol. 2005 Nov; 4(11):743-51.
Score: 0.237
-
Bushnell CD. The Women's Health Initiative trial and stroke risk. Lancet Neurol. 2002 Sep; 1(5):277.
Score: 0.191
-
Coker LH, Espeland MA, Hogan PE, Resnick SM, Bryan RN, Robinson JG, Goveas JS, Davatzikos C, Kuller LH, Williamson JD, Bushnell CD, Shumaker SA. Change in brain and lesion volumes after CEE therapies: the WHIMS-MRI studies. Neurology. 2014 Feb 04; 82(5):427-34.
Score: 0.105
-
Parsons E, Newby LK, Bhapkar MV, Alexander KP, White HD, Shah SH, Bushnell CD, Califf RM. Postmenopausal hormone use in women with acute coronary syndromes. J Womens Health (Larchmt). 2004 Oct; 13(8):863-71.
Score: 0.055
-
Espeland MA, Tindle HA, Bushnell CA, Jaramillo SA, Kuller LH, Margolis KL, Mysiw WJ, Maldjian JA, Melhem ER, Resnick SM. Brain volumes, cognitive impairment, and conjugated equine estrogens. J Gerontol A Biol Sci Med Sci. 2009 Dec; 64(12):1243-50.
Score: 0.019